Drug firm Sanofi India has signed a Memorandum of Understanding (MoU) with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata, to promote academic excellence and research.
The pact with NIPER "will promote academic excellence and research in the areas of pharmaceuticals and consumer healthcare products, to cater to the current and future needs of the pharmaceutical industry," Sanofi India said in a filing to BSE.
As per the pact, the company will provide opportunities of internship or project work to NIPER Kolkata MS/PhD students at manufacturing sites, ensure association of R&D heads with the dissertation work, provide career growth opportunities and undertake collaborative research activities in identified areas, it added.
The agreement was signed in the presence of President Pranab Mukherjee, Sanofi India informed.
Commenting on the development, Sanofi India MD Shailesh Ayyangar said: "The era of academia-industry collaboration to address the mammoth task of capacity building to meet our healthcare challenges has well and truly begun." Shares of Sanofi India Ltd were today closed 0.39 percent down at Rs 4,179.25 apiece on BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
